Swiss Severe Asthma Registry (SSAR)- Good asthma control and high number of exacerbations. How does this fit?

F. Jaun (Liestal, Switzerland), J. Capponi (Liestal, Switzerland), A. Jochmann (Basel, Switzerland), N. Pavlov (Bern, Switzerland), L. Kern (St.Gallen, Switzerland), S. Widmer (St.Gallen, Switzerland), C. Clarenbach (Zürich, Switzerland), N. Sievi (Zürich, Switzerland), C. Steurer-Stey (Zürich, Switzerland), H. Duchna (Davos, Switzerland), T. Rothe (Chur, Switzerland), M. Dinic (Chur, Switzerland), C. Oberhänsli (Davos, Switzerland), P. Gianella (Lugano, Switzerland), M. Paronitti Lovera (Lugano, Switzerland), F. Charbonnier (Geneva, Switzerland), M. Salamin (Sion, Switzerland), P. Bridevaux (Sion, Switzerland), C. Von Garnier (Lausanne, Switzerland), J. Leuppi (Liestal, Switzerland)

Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Jaun (Liestal, Switzerland), J. Capponi (Liestal, Switzerland), A. Jochmann (Basel, Switzerland), N. Pavlov (Bern, Switzerland), L. Kern (St.Gallen, Switzerland), S. Widmer (St.Gallen, Switzerland), C. Clarenbach (Zürich, Switzerland), N. Sievi (Zürich, Switzerland), C. Steurer-Stey (Zürich, Switzerland), H. Duchna (Davos, Switzerland), T. Rothe (Chur, Switzerland), M. Dinic (Chur, Switzerland), C. Oberhänsli (Davos, Switzerland), P. Gianella (Lugano, Switzerland), M. Paronitti Lovera (Lugano, Switzerland), F. Charbonnier (Geneva, Switzerland), M. Salamin (Sion, Switzerland), P. Bridevaux (Sion, Switzerland), C. Von Garnier (Lausanne, Switzerland), J. Leuppi (Liestal, Switzerland). Swiss Severe Asthma Registry (SSAR)- Good asthma control and high number of exacerbations. How does this fit?. 1099

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry
Source: Eur Respir J, 56 (6) 2002857; 10.1183/13993003.02857-2020
Year: 2020



Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study
Source: International Congress 2016 – Asthma points to ponder
Year: 2016

Childhood obesity in relation to poor asthma control and exacerbations
Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies
Year: 2016


Occupational asthma as a result of severe asthma
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015

The German Severe Asthma Registry: Obesity is associated with asthma parameters
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020


Serious asthma exacerbations in a hospital setting
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014


Discordance between asthma control parameters in patients with frequent vs infrequent asthma exacerbations
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014

Late Breaking Abstract - Characteristics of T2-biomarker low severe asthma patients in the UK Severe Asthma Registry (UKSAR)
Source: International Congress 2019 – Asthma epidemiology in the 21st century
Year: 2019

Introduction of new asthma guidelines did not improve asthma control in a Dutch paediatric population
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014


Gender and its relation to asthma phenotype and comorbidities in difficult-to-control asthma patients from Czech National Severe Asthma Registry
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008


Chronic oral corticosteroids use and persistent eosinophilia in severe asthma. The Belgian Severe Asthma Registry.
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020


Characterization of asthma exacerbations in outpatients – National survey
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


Infection associated phenotype of asthma: Results of a difficult asthma clinic service improvement project
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


Risk factors for poor asthma control in asthmatic children
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014


Patients with allergic and eosinophilic asthma in the German severe asthma registry
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015


Development of binary forecast models of asthma exacerbation: Asthma index
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014

Sesonal variations of severe asthma exacerbations in the US
Source: International Congress 2014 – Risk factors for respiratory disease
Year: 2014

Asthma clusters in a real asthmatic population, treated in secondary medical care
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014

Pattern of asthma control and inhaled corticosteroid (ICS) use in an Australian asthma population
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013


Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014